Generic drugs

Generic Drugs Market to Register Growth of $138.9 Billion – Technavio Identifies North America as a Key Growth Region

NEW YORK, July 27, 2022 /PRNewswire/ — The “Generic Drugs Market by Type and Geography – Forecast and Analysis 2021-2025“a Technavio report expects the market size to increase by $138.9 billion between 2020 and 2025. The market grew at a CAGR of 5.95% in 2021 and the growth momentum is expected to accelerate at a CAGR of 6.33% during the forecast period. The report provides a comprehensive analysis of recent developments, new product launches, major revenue-driving segments, and market behavior across all geographies. Download sample PDF report here

Technavio has announced its latest market research report titled Generic Drugs Market by Type and Geography – Forecast and Analysis 2021-2025

The global generic drugs market is fragmented and characterized by global and regional vendors. Suppliers partner with research organizations and hospitals for R&D and participate in various scientific conferences to showcase their products and explore long-term development opportunities. The major vendors in the global generic drugs market are focusing on product approvals, mergers and acquisitions, and product launches to gain a competitive edge in the market. Inorganic growth strategies, robust R&D and pricing strategies will also increase the competition among these vendors.

Technavio identifies Amgen Inc., Dr. Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. among the major players in the market. Although the availability of low-cost alternatives, increased outsourcing of drug discovery and development, and increasing drug patent expirations will provide immense opportunities for growth, growing credibility issues, side effects growth and strict regulations will test the growth of market players. To make the most of the opportunities, sellers in the market should focus more on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Download sample report now

The generic drugs market is segmented as follows:

The small molecule generics segment will hold the largest market share. The availability of generic drugs at discounted prices is driving the growth of the segment. In addition, the emergence of super generics, the lower investment required by manufacturers and the simplification of synthetic chemical reactions to produce exact copies of the product are contributing to the growth of the segment.

39% of market growth will come from North America during the forecast period. The presence of a large number of key vendors who offer a variety of highly differentiated products is driving the growth of the regional market. Additionally, the increase in the prevalence of major health disorders is mainly due to lifestyle changes, and the increase in the consumption of alcohol and tobacco in the United States will have a positive impact on the growth of the market. generic drugs in the United States. North America. Technavio presents a detailed picture of the market through study, synthesis and summation of data from multiple sources. Our Generic Drugs Market report covers the following areas:

Generic Drugs Market 2021-2025: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the generic drug market, including some of the dominant vendors. Leveraging on competitive intelligence and benchmarking, our Generic Drugs Market research report is designed to provide entry assistance, customer profiling and M&A as well as strategy support of placing on the market.

Generic Drugs Market 2021-2025: Key Highlights

  • Market CAGR over the forecast period 2021-2025

  • Detailed information on the factors that will contribute to the growth of the generic drugs market over the next five years

  • Estimation of the generic drugs market size and its contribution to the parent market

  • Predictions on upcoming trends and changes in consumer behavior

  • The growth of the generic drug market

  • Market Competitive Landscape Analysis and Detailed Vendor Information

  • Comprehensive details of the factors that will challenge the growth of the Generic Drugs Market vendors

Related reports:

Generic Drugs Market Scope

Report cover


Page number


base year


Forecast period


Growth momentum and CAGR

Accelerate at a CAGR of 6.33%

Market Growth 2021-2025

$138.9 billion

Market structure


Annual growth (%)


Regional analysis

North America, Europe, Asia and ROW

Successful market contribution

North America at 39%

Main consumer countries

United States, Germany, China, Japan and United Kingdom

Competitive landscape

Leading companies, competitive strategies, scope of consumer engagement

Profiled companies

Amgen Inc., Dr. Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and Viatris Inc..

Market dynamics

Parent market analysis, market growth drivers and barriers, analysis of fast growing and slow growing segments, impact of COVID 19 and future consumer dynamics, and analysis of market conditions for the forecast period.

Personalization area

If our report does not include the data you are looking for, you can contact our analysts and customize the segments.


1. Summary

2 Market landscape

3 Market sizing

4 Five forces analysis

5 Market Segmentation by Type

6 Customer Landscape

7 Geographic landscape

8 drivers, challenges and trends

9 Supplier landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a global leader in technology research and consulting. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialist analysts, Technavio’s reporting library consists of over 17,000 reports and counts, spanning 800 technologies, spanning 50 countries. Their customer base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, in-depth research, and actionable market intelligence to identify opportunities in existing markets and potentials and assess their competitive positions in changing market scenarios.


Technavio Research
Jesse Maida
Media & Marketing Manager
USA: +1 844 364 1100
UK: +44 203 893 3200
E-mail: [email protected]

Technavio (PRNewsfoto/Technavio)

Technavio (PRNewsfoto/Technavio)



See original content to download multimedia:–technavio-identifies-north- america-as-a-key-growth-region-301593342.html


Joan J. Dean

The author Joan J. Dean